PAVMW (PAVmed) Tariff Resilience Score: 7/10 (As of Jul. 03, 2026)


PAVMW PAVmed Inc PAVMW
32 GF Score
Price $0.03
! 6 Warning Signs
View Full Analysis

What is PAVmed Tariff Resilience Score?

PAVmed PAVMW 32 Tariff Resilience Score is 7 as of Jul. 03, 2026. GuruFocus rates PAVMW with a GF Score™ of 32/100. The stock has 6 warning signs investors should review. Among 838 Medical Devices & Instruments companies, PAVmed ranks better than 98.09% on this metric.

PAVmed has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

PAVmed has PAVmed, a medical device company, has moderate tariff exposure. While it imports components, the medical industry often benefits from tariff exemptions, and the company can adjust pricing to mitigate impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes PAVmed might have Highly Resilient.

PAVmed  (NAS:PAVMW) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

PAVmed Tariff Resilience Score Related Terms

PAVMW vs BDMD, TELA, NSPR: Tariff Resilience Score Comparison

For the Medical Devices subindustry, PAVmed's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PAVmed Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PAVmed's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where PAVmed's Tariff Resilience Score falls into.


PAVMW
32GF Score
PAVmed Inc PAVMW
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
PAVmed (PAVMW) has a Tariff Resilience Score of 7 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, PAVmed ranks #16 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is PAVmed's Tariff Resilience Score too high?
PAVmed's current Tariff Resilience Score is 7. Based on the distribution chart, PAVmed ranks #16 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PAVmed has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PAVmed's Tariff Resilience Score compare to BDMD and TELA?
According to the Medical Devices & Instruments industry distribution chart, PAVmed ranks #16 out of 838 companies for Tariff Resilience Score. This places PAVmed in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. PAVmed's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAVmed stock overvalued right now?
PAVmed (PAVMW) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7. PAVmed's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For PAVmed (PAVMW), the current Tariff Resilience Score is 7 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PAVmed Business Description

Other Exchanges PAVM:USA
Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
32GF Score

Get the complete analysis for PAVMW

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price